M V Relling - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M V Relling

Showing results (121-130 of 176) with videos related to

Pageof 18

Sort By:

Leukemia|October 10, 1998

Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.

Blood|February 25, 1999

Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulationV M Belkov, E Y Krynetski, J D Schuetz, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999

Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.

Clinical Pharmacology and Therapeutics|August 8, 2008

Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.

Leukemia|November 13, 2010

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.

Leukemia|August 11, 1998

Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.

Clinical Pharmacology and Therapeutics|October 29, 2010

Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemiaN Pottier, S W Paugh, C Ding, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001

Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaJ G Blanco, T Dervieux, M J Edick, et al.

Clinical Pharmacology and Therapeutics|January 29, 2011

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.

Pageof 18

Search research articles

Showing results (121-130 of 176) with videos related to

Sort By:

Pageof 18

Leukemia|October 10, 1998

Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.

Blood|February 25, 1999

Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulationV M Belkov, E Y Krynetski, J D Schuetz, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999

Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui, H H Mahmoud, J M Wiley, et al.

Clinical Pharmacology and Therapeutics|August 8, 2008

Leukemia|November 13, 2010

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.

Leukemia|August 11, 1998

Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.

Clinical Pharmacology and Therapeutics|October 29, 2010

Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemiaN Pottier, S W Paugh, C Ding, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001

Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaJ G Blanco, T Dervieux, M J Edick, et al.

Clinical Pharmacology and Therapeutics|January 29, 2011

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.

Pageof 18